By The United States Sentencing Commission

  More than 780,000 Americans died from a drug overdose in the last ten years. Overdose deaths have increased more than 300 percent from the level two decades ago. The number of such deaths has continued to increase in recent years, with the Centers for Disease Control reporting that 91,799 people died of drug overdoses in 2020, 106,699 in 2021, 107,941 in 2022, and 105,007 in 2023. Provisional data shows a recent decline in overdose deaths beginning in late 2023 and continuing into 2024. Overdoses remain one of the leading causes of deaths in adults in the United States. While fentanyl and fentanyl analogues, methamphetamine, cocaine, and heroin are the drugs most often involved in these deaths, synthetic opioids like fentanyl— which is up to 50 times more potent than heroin—contribute to nearly 70 percent of overdose deaths. In this report, the Commission examines all overdoses identified in drug trafficking cases reported to the Commission for fiscal years 2019 to 2023. One or more deaths occurred in more than three-quarters of these cases, while no deaths occurred in the remaining cases. The Commission is able to collect information about the overdoses reported in these cases through the sentencing documents the courts provide to the Commission in every case.8 Using that information, this report provides an analysis of the 1,340 individuals sentenced for a federal drug trafficking offense involving an overdose in fiscal years 2019 to 2023. In it, the Commission analyzes the demographic characteristics of these individuals, the offense conduct that occurred in the case, and how the courts sentenced these individuals—including the application of sentencing guideline provisions that provide for heightened base offense levels when the offense of conviction established that death or serious bodily injury resulting from an overdose occurred, or departures from the guideline range for death or physical injury, or how often courts varied from the guideline range for a similar reason. Additionally, in this report, the Commission provides the results of a special data collection project to explore the outcome of each overdose, the type of drug involved in the overdose, the victim’s knowledge of the drug they were taking, and the sentenced individual’s conduct during the offense.  

Washington, DC, USSC, 2025.   52p.

By Harjeev Kour Sudan, Andy Man Yeung Tai, Jane Kim, and Reinhard Michael Krausz

Introduction: The Dark Web is a subsection of the Internet only accessible through specific search engines, making it impossible to trace users. Due to extensive anonymity, the drug trade on the Dark Web makes regulation complicated. We sought to uncover the scope of the online drug trade on the Dark Web and the impact it may have on the dynamics of global drug trafficking.

Methods: We conducted a literature review to elucidate the availability and distribution of drugs on the Dark Web based on data reported in existing literature (n = 14) between September 2012 and June 2019. We simultaneously collected data about substances and listings from Dark Web cryptomarkets (n = 13) active between August 2022 and January 2023. Data from the literature review and the Dark Web scrape were combined to draw trends in the chronological availability and distribution of drugs between 2012 and 2023.

Results: The data collected from 13 cryptomarkets between late 2022 and early 2023 showed a relative change in substance distribution compared to 2012–2019, with a decrease in prescription drugs (from >20% to <5%) and a doubling of opioid listings (from 5.5% to 9.25%), while no major changes were observed on average during 2012–2019 according to literature.

Conclusions: The Dark Web warrants more attention in the analysis of the global drug trade. Understanding Dark Web drug markets can inform targeted interventions and strategies to reduce drug-related harms, while ongoing research is necessary to anticipate and respond to future changes in the landscape of the illicit drug trade.

Drug Science, Policy and Law Volume 9 January-December 2023

By The National Audit Office (NAO) (UK)

The distribution, sale and consumption of illegal drugs causes significant harm to individuals, families and communities. In 2021, almost 3,000 people in England died because of drug misuse and thousands more suffered complex health problems. The government also estimated that around three million people in England and Wales take illegal drugs at a cost to society of approximately £20 billion a year. The drugs trade generates significant levels of violence and is believed to be responsible for around half of all murders in England and Wales.

Tackling the problems caused by illegal drugs is complex. It involves disrupting the organised gangs which supply and distribute drugs, and providing effective treatment and recovery services to help people with addictions. The government announced a £900 million increase in funding for 2022-23 to 2024-25 and committed to long-term targets to reduce drug use and drug-related crime and deaths. The government established the cross-government Joint Combating Drugs Unit (JCDU) to co-ordinate and oversee the development and implementation of the strategy.

t is almost two years since the government introduced its latest drugs strategy and less than 18 months remain in the current funding period to March 2025. This report examines whether the government is well positioned to achieve the strategy’s 10-year ambitions. It covers:

the development of the 2021 drugs strategy, its objectives and funding

progress in implementing the strategy

the approach to achieving the strategy’s long-term outcomes

It is too early to conclude whether the 2021 strategy will reduce the harm from illegal drugs. It will take time for new funding and interventions to address a complex set of issues, and many of the indicators used to measure progress lag behind activity. This report therefore assesses whether departments are making the planned progress in implementing the strategy, and whether the JCDU has an effective approach to understanding the impact it is having and managing the risks to achieving the strategy’s aims. It does not examine the effectiveness of interventions at the local level.

Conclusions

In 2021 the government estimated that the harm caused by illegal drugs costs society £20 billion each year. Its 2021 drugs strategy, led by the cross-government Joint Combating Drugs Unit, has provided new impetus to efforts to address these harms, and committed £900 million to 2024-25.

The strategy has established new partnerships across central and local government, and local authorities are taking steps to rebuild the workforce that was lost over the past decade. But these measures alone will not address all of the barriers to achieving a long-term reduction in drug use, deaths and related crime. The issues are complex and will require a sustained long-term response.

To inform government’s response, the JCDU and relevant departments need to develop a deeper understanding of the impacts of government spending, working closely with local service providers to understand and help address the practical challenges they face. The JCDU and departments need to be realistic about what is achievable in the first three years and assess how to adapt their approach to achieve the strategy’s 10-year outcomes.

In doing so, the JCDU should seek to provide confidence to local government: that this is a long-term commitment. It must also urgently develop a plan to reduce the demand for illegal drugs. The current lack of emphasis on preventing illegal drug use means that departments risk only addressing the consequences, rather than the causes, of harm. The government will only achieve value for money if it builds on the initial momentum of the new strategy and develops a longer-term, funded plan that delivers a joined-up, holistic response.

London: The National Audit Office (NAO), 2023. 56p.

Edited by Danilo Antonio Baltieri

This book covers some recent researches on the interface between drug misuse and crime and demonstrates that some types of violent crimes are more intimately related to alcohol and / or drug consumption. It is written for researchers, health and law professionals engaged in the evaluation, management and treatment of different types of offenders. It is organized by a number of phenomena that are known (or supposed) to link drugs and crime. This book shows that the application of punishment under the guise of deterrence, despite its ineffectiveness, is frequently preferred to a more adequate management for some types of offenders. This book provides ten manuscripts that describe different aspects of the relationship between drugs and crimes, always focusing on Brazilian reality. It shows that a partnership between specialized mental health professionals, lawyers and policy makers is urgent with respect to this subject in Brazil and other countries.

Bentham Books, 2009. 100p.

By John Coyne and Teagan Westendorf

THis report helps develop an understanding of the quantum of profits being made and where in the value chain they occur. Australians spent approximately A$5.8 billion on methamphetamine and A$470 million on heroin in FY 2019.

Approximately A$1,216,806,017 was paid to international wholesalers overseas for the amphetamine and heroin that was smuggled into Australia in that year. The profit that remained in Australia’s economy was about A$5,012,150,000. Those funds are undermining Australia’s public health and distorting our economy daily, and ultimately funding drug cartels and traffickers in Southeast Asia.

One key takeaway from the figures presented in this report is that the Australian drug trade is large and growing. Despite the best efforts of law enforcement agencies, methamphetamine and heroin use has been increasing by up to 17% year on year. Falling prices in Southeast Asia are likely to keep pushing that number up, while drug prices and purity in Australia remain relatively stable.

Canberra: Australian Strategic Policy Institute, 2021. 40p.